Niraparib and Bevacizumab Maintenance Therapy in Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor
Clinical trial NCT04734665 · UNKNOWN
Trial details
- NCT number
- NCT04734665
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-05
- Primary completion
- 2023-03-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.